SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-043391
Filing Date
2024-05-15
Accepted
2024-05-15 13:32:12
Documents
78
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0206027-10q_incannex.htm   iXBRL 10-Q 595953
2 CERTIFICATION ea020602701ex31-1_incannex.htm EX-31.1 9560
3 CERTIFICATION ea020602701ex31-2_incannex.htm EX-31.2 9529
4 CERTIFICATION ea020602701ex32-1_incannex.htm EX-32.1 3754
5 CERTIFICATION ea020602701ex32-2_incannex.htm EX-32.2 3906
  Complete submission text file 0001213900-24-043391.txt   4252796

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE ixhl-20240331.xsd EX-101.SCH 56901
7 XBRL CALCULATION FILE ixhl-20240331_cal.xml EX-101.CAL 29446
8 XBRL DEFINITION FILE ixhl-20240331_def.xml EX-101.DEF 218488
9 XBRL LABEL FILE ixhl-20240331_lab.xml EX-101.LAB 429814
10 XBRL PRESENTATION FILE ixhl-20240331_pre.xml EX-101.PRE 230879
82 EXTRACTED XBRL INSTANCE DOCUMENT ea0206027-10q_incannex_htm.xml XML 472187
Mailing Address 401 DOCKLANDS DRIVE SUITE 15, LEVEL 12 DOCKLANDS, VICTORIA C3 3008
Business Address 401 DOCKLANDS DRIVE SUITE 15, LEVEL 12 DOCKLANDS, VICTORIA C3 3008 61 409 840 786
Incannex Healthcare Inc. (Filer) CIK: 0001873875 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-41106 | Film No.: 24949065
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)